利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

57 条记录 (耗时 0.034 秒)

    OSMOTIC WATER TRANSFER SYSTEM AND RELATED PROCESSES
    1.
    发明公开
    OSMOTIC WATER TRANSFER SYSTEM AND RELATED PROCESSES 审中-公开
    渗透水运输系统和关联方法

    公开(公告)号：EP2509706A2

    公开(公告)日：2012-10-17

    申请号：EP10836792.1

    申请日：2010-12-12

    申请人： Hydration Systems, Llc

    发明人： HERRON, John, R. ,  BEAUDRY, Edward

    IPC分类号： B01D61/08 ,  B01D63/00 ,  C02F1/44

    CPC分类号： B01D61/002 ,  B01D63/10 ,  B01D71/10 ,  B01D2317/04 ,  C02F1/445

    摘要： A forward osmosis water transfer system is disclosed which recycles water from an incoming wastewater stream into an outgoing dilute process brine stream. The system includes a saturated brine stream, a first portion of which is diverted to form a saturated process brine stream and a second portion of which is diverted to at least one forward osmosis membrane. The at least one forward osmosis membrane moves water from the incoming wastewater stream into the incoming diverted saturated brine stream thereby creating an outgoing concentrated wastewater stream and the outgoing dilute process brine stream.

    Peptide-based passive immunization therapy for treatment of atherosclerosis
    4.
    发明公开
    Peptide-based passive immunization therapy for treatment of atherosclerosis 审中-公开
    Auf Peptiden basierende被动Immunisierungstherapie zur Behandlung von Atherosklerose

    公开(公告)号：EP2359848A1

    公开(公告)日：2011-08-24

    申请号：EP10075393.8

    申请日：2003-10-06

    申请人： BioInvent International AB

    发明人： Nilsson, Jan ,  Bengtsson, Jenny ,  Strandberg, Leif ,  Carlsson, Roland

    IPC分类号： A61K39/00

    CPC分类号： C07K14/775 ,  A61K2039/505 ,  C07K16/18 ,  C07K2317/21 ,  C07K2317/622

    摘要： The present invention relates to passive immunization for treating or preventing atherosclerosis using an isolated human antibody directed towards at least one oxidized fragment of apolipoprotein B in the manufacture of a pharmaceutical composition for therapeutical of prophylactical treatment of atherosclerosis by means of passive immuni-retion, as well as method for preparing such antibodies, and a method for treating a mammal, preferably a human using such an antibody to provide for passive immunization.

    摘要翻译： 本发明涉及用于治疗或预防动脉粥样硬化的被动免疫，其使用针对至少一种载脂蛋白B的氧化片段的分离的人抗体制造用于通过被动免疫反应来预防性治疗动脉粥样硬化的药物组合物，作为 以及用于制备此类抗体的方法以及使用这种抗体治疗哺乳动物，优选人的方法以提供被动免疫。

    CNS PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
    6.
    发明公开
    CNS PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE 审中-公开
    ZNS-PHARMAZEUTIKA UND VERFAHRENFÜRIHRE VERWENDUNG

    公开(公告)号：EP2254420A2

    公开(公告)日：2010-12-01

    申请号：EP09711567.9

    申请日：2009-02-20

    申请人： Targia Pharmaceuticals

    发明人： GLOZMAN, Sabina

    IPC分类号： A01N59/16

    CPC分类号： A61K31/137 ,  A61K31/00 ,  A61K31/09 ,  A61K31/27 ,  A61K31/5377 ,  A61K31/5513 ,  A61K31/5517 ,  A61K31/554 ,  A61K45/06 ,  A61K2300/00

    摘要： The present invention is directed to CNS pharmaceutical compositions and methods of use. The pharmaceutical compositions comprise a CNS active agent and preferably at least two vagal neuromodulators, one of which is a mechanoreceptor stimulator. The vagal neuromodulators are preferably in an amount sufficient to reduce a side-effect of the CNS active agent. The invention further encompasses a method of reducing CNS active agent side-effects. The method typically comprises administering the CNS active agent to a patient; and administering at least two vagal neuromodulators to the patient so that at least one neuromodulator is administered or released after the CNS active agent is administered or released.

    摘要翻译： 本发明涉及CNS药物组合物和使用方法。 药物组合物包含CNS活性剂，优选至少两种迷走神经调节剂，其中之一是机械受体刺激剂。 迷走神经调节剂优选以足以降低CNS活性剂的嗜睡副作用而不改变其治疗功效/活性的量。 本发明还包括减少CNS活性剂副作用的方法。 该方法通常包括以常规接受的剂量向患者口服至少一种CNS活性剂; 并向患者施用至少两种迷走神经调节剂，使得至少一种神经调节剂在CNS活性剂被施用和/或释放之后从剂型给药或释放。